Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations

Nat Genet. 2020 Jul;52(7):748-749. doi: 10.1038/s41588-020-0663-9.

Oana M Enache^#¹, Veronica Rendo^#², Mai Abdusamad¹, Daniel Lam¹, Desiree Davison¹, Sangita Pal², Naomi Currimjee², Julian Hess¹, Sasha Pantel³, Anwesha Nag⁴, Aaron R Thorner⁴, John G Doench³, Francisca Vazquez¹, Rameen Beroukhim^{1

2

5}, Todd R Golub^{1

5

6

7}, Uri Ben-David^{8

9}

¹ Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
² Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
³ Genetic Perturbation Platform, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
⁴ Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA, USA.
⁵ Harvard Medical School, Boston, MA, USA.
⁶ Howard Hughes Medical Institute, Chevy Chase, MD, USA.
⁷ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁸ Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA. ubendavid@tauex.tau.ac.il.
⁹ Department of Human Molecular Genetics & Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ubendavid@tauex.tau.ac.il.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.